Vanda Pharmaceuticals, Inc. (VNDA)
5.43
+0.09
(+1.69%)
USD |
NASDAQ |
Sep 04, 16:00
5.43
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Price : 5.43 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 5.29 | 5.45 | 5.29 | 5.43 | 589448.0 |
| Sep 03, 2026 | 5.55 | 5.59 | 5.295 | 5.34 | 756161.0 |
| Sep 02, 2026 | 5.40 | 5.64 | 5.38 | 5.53 | 621096.0 |
| Sep 01, 2026 | 5.36 | 5.435 | 5.32 | 5.42 | 584852.0 |
| Aug 31, 2026 | 5.23 | 5.45 | 5.205 | 5.40 | 777316.0 |
| Aug 28, 2026 | 5.40 | 5.435 | 5.22 | 5.29 | 525316.0 |
| Aug 27, 2026 | 5.35 | 5.48 | 5.27 | 5.44 | 545582.0 |
| Aug 26, 2026 | 5.43 | 5.43 | 5.24 | 5.35 | 928371.0 |
| Aug 25, 2026 | 5.34 | 5.500 | 5.34 | 5.44 | 876367.0 |
| Aug 24, 2026 | 5.335 | 5.37 | 5.20 | 5.33 | 774295.0 |
| Aug 21, 2026 | 5.42 | 5.42 | 5.265 | 5.28 | 656793.0 |
| Aug 20, 2026 | 5.52 | 5.52 | 5.315 | 5.38 | 915774.0 |
| Aug 19, 2026 | 5.50 | 5.59 | 5.39 | 5.57 | 898030.0 |
| Aug 18, 2026 | 5.23 | 5.48 | 5.23 | 5.44 | 996308.0 |
| Aug 17, 2026 | 5.15 | 5.335 | 5.13 | 5.26 | 795412.0 |
| Aug 14, 2026 | 5.04 | 5.28 | 4.955 | 5.22 | 965068.0 |
| Aug 13, 2026 | 5.20 | 5.24 | 4.995 | 5.03 | 864990.0 |
| Aug 12, 2026 | 4.95 | 5.26 | 4.92 | 5.19 | 1.076M |
| Aug 11, 2026 | 5.05 | 5.09 | 4.849 | 4.93 | 1.065M |
| Aug 10, 2026 | 4.93 | 5.065 | 4.80 | 5.02 | 2.001M |
| Aug 07, 2026 | 5.16 | 5.17 | 4.97 | 5.00 | 1.307M |
| Aug 06, 2026 | 4.64 | 5.20 | 4.448 | 5.115 | 2.340M |
| Aug 05, 2026 | 5.33 | 5.41 | 5.04 | 5.09 | 1.601M |
| Aug 04, 2026 | 5.24 | 5.39 | 5.20 | 5.33 | 727495.0 |
| Aug 03, 2026 | 5.10 | 5.26 | 5.02 | 5.23 | 719845.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Protagonist Therapeutics, Inc. | 145.72 |
| ACADIA Pharmaceuticals, Inc. | 28.02 |
| Alnylam Pharmaceuticals, Inc. | 266.11 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
Price Related Metrics
| PS Ratio | 1.497 |
| PEG Ratio | -0.0038 |
| Price to Book Value | 1.491 |
| Earnings Yield | -85.19% |
| Market Cap | 328.27M |
| PEGY Ratio | -0.0038 |